Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

17.830
+1.3308.06%
Volume:71.33M
Turnover:1.27B
Market Cap:45.11B
PE:4.45
High:18.650
Open:16.420
Low:16.200
Close:16.500
52wk High:36.264
52wk Low:14.594
Shares:2.53B
HK Float Shares:2.53B
Volume Ratio:2.49
T/O Rate:2.82%
Dividend:0.26
Dividend Rate:1.47%
EPS(LYR):4.002
ROE:35.88%
ROA:22.68%
PB:1.40
PE(LYR):4.45
PS:2.16

Loading ...

Assessing 3SBio (SEHK:1530) Valuation After Strong 2025 Earnings And Affirmed Dividend

Simply Wall St.
·
Apr 13

Can Southbound Capital Propel 3SBIO's Stock Rebound Post-Earnings?

Stock News
·
Apr 10

3SBio Sets 23 April 2026 Vote on In-Specie Dividend of Mandi Shares as Part of Planned Spin-Off

Bulletin Express
·
Apr 01

3SBio Convenes 23 April 2026 EGM to Ratify In-Specie Special Dividend of Full Mandi Inc. Shareholding

Bulletin Express
·
Apr 01

3SBio announces extraordinary general meeting to approve Mandi shares distribution dividend

Reuters
·
Apr 01

Stock Track | 3SBIO Soars 11.66% Intraday as CICC Maintains Outperform Rating with 61% Upside Target

Stock Track
·
Apr 01

CICC Maintains Outperform Rating on 3SBIO with HK$36.5 Target Price

Stock News
·
Apr 01

3SBio - 2025 Adj Net Profit Attributable to Shareholders RMB 8.45 Bln, up 264.6% YoY

THOMSON REUTERS
·
Mar 31

3SBio - Declares 2025 Final Dividend of HKD 0.25 per Share

THOMSON REUTERS
·
Mar 31

3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone

prnewswire
·
Mar 31

3SBio (SEHK:1530) Valuation Check After Strong 2025 Sales And Earnings Growth

Simply Wall St.
·
Mar 31

3SBIO Reports Fiscal Year Profit Attributable to Owners Soars 305.8% to RMB 8.482 Billion

Stock News
·
Mar 30

3SBio to Spin Off Mandi Inc.; Board Declares Conditional Special Dividend via Distribution in Specie

Bulletin Express
·
Mar 30

3SBio Declares HKD0.25 Final Dividend for FY-2025

Bulletin Express
·
Mar 30

3SBio proposes final dividend of HKD 0.25 per share

Reuters
·
Mar 30

3SBio FY25 net profit jumps to RMB 8.5 billion; revenue rises 94.3% to RMB 18 billion

Reuters
·
Mar 30

Alphamab Oncology Names Former 3SBio Executive as CFO

MT Newswires Live
·
Mar 18

CMB International Foresees Accelerated Fundamental Improvement in China's Healthcare Sector, Recommends Buying Innovent Bio, 3SBIO, and Others

Stock News
·
Mar 17

Biopharma Stocks Rally as Sector Gains Strategic "Emerging Pillar" Status

Stock News
·
Mar 06

3SBio Inc. (01530) Publishes February 2026 Monthly Securities Return

Bulletin Express
·
Mar 03